A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies ; volume:12 ; number:10 ; year:2023 ; extent:18
ChemistryOpen ; 12, Heft 10 (2023) (gesamt 18)
- Urheber
-
Eissa, Ibrahim H.
Yousef, Reda G.
Elkady, Hazem
Elkaeed, Eslam B.
Alsfouk, Aisha A.
Husein, Dalal Z.
Ibrahim, Ibrahim M.
Radwan, Mohamed M.
Metwaly, Ahmed M.
- DOI
-
10.1002/open.202300066
- URN
-
urn:nbn:de:101:1-2023100715081152054988
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eissa, Ibrahim H.
- Yousef, Reda G.
- Elkady, Hazem
- Elkaeed, Eslam B.
- Alsfouk, Aisha A.
- Husein, Dalal Z.
- Ibrahim, Ibrahim M.
- Radwan, Mohamed M.
- Metwaly, Ahmed M.
Ähnliche Objekte (12)
In-Silico Design of an Anti-Cancer Vaccine
Anticancer activity of benzoxazole derivative (2015 onwards): a review
Targeting CDK9 for anti-cancer therapeutics
Targeting mitochondria as an anticancer strategy
Repurposing metformin as a potential anticancer agent using in silico technique
Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway
Carvacrol potentiates immunity and sorafenib anti-cancer efficacy by targeting HIF-1α/STAT3/ FGL1 pathway: in silico and in vivo study
In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Medicinal attributes of pyridine scaffold as anticancer targeting agents
A chalcone derivative SBD-2 exerts anticancer effects in human colorectal cancer cells
Targeting CD44v6, a co-receptor for Met and VEGFR-2 in endothelial cells, inhibits tumour angiogenesis
Targeting serotonin receptors with phytochemicals – an in-silico study
In-Silico Design of an Anti-Cancer Vaccine
Anticancer activity of benzoxazole derivative (2015 onwards): a review
Targeting CDK9 for anti-cancer therapeutics
Targeting mitochondria as an anticancer strategy
Repurposing metformin as a potential anticancer agent using in silico technique
Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway
Carvacrol potentiates immunity and sorafenib anti-cancer efficacy by targeting HIF-1α/STAT3/ FGL1 pathway: in silico and in vivo study
In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Medicinal attributes of pyridine scaffold as anticancer targeting agents
A chalcone derivative SBD-2 exerts anticancer effects in human colorectal cancer cells
Targeting CD44v6, a co-receptor for Met and VEGFR-2 in endothelial cells, inhibits tumour angiogenesis
Targeting serotonin receptors with phytochemicals – an in-silico study
In-Silico Design of an Anti-Cancer Vaccine
Anticancer activity of benzoxazole derivative (2015 onwards): a review
Targeting CDK9 for anti-cancer therapeutics
Targeting mitochondria as an anticancer strategy
Repurposing metformin as a potential anticancer agent using in silico technique
Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway
Carvacrol potentiates immunity and sorafenib anti-cancer efficacy by targeting HIF-1α/STAT3/ FGL1 pathway: in silico and in vivo study
In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Medicinal attributes of pyridine scaffold as anticancer targeting agents
A chalcone derivative SBD-2 exerts anticancer effects in human colorectal cancer cells
Targeting CD44v6, a co-receptor for Met and VEGFR-2 in endothelial cells, inhibits tumour angiogenesis